TP53 and choriocarcinoma: LRSAM1 knockdown hinders choriocarcinoma progression, inhibiting choriocarcinoma cell proliferating, migratory flow, and invasive force and accelerating cell apoptotic process experimentally and experimentally via p53/p21 signaling activation.